Regulation of Stress granules in response to lysosomal damage
Regulation of Stress granules in response to lysosomal damage
批准号:
10814130
负责人:
Jingyue jia cassano
金额:
$23.16万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-01 至 2027-08-31
关键词:
AutophagocytosisCell physiologyCellsCellular StressDetectionDiseaseEtiologyFRAP1 geneGalactose Binding LectinGoalsHomeostasisInflammationKnowledgeLinkLysosomesMetabolismMolecularPhasePhysical condensationProcessProtein BiosynthesisPublicationsRecyclingRegulationRegulatory PathwayReportingSignal PathwaySignal TransductionTherapeuticTranslationsfield studyhuman diseasemessenger ribonucleoproteinnormal agingrepairedresponsestress granule
中文摘要
溶酶体损伤是细胞稳态和存活的主要威胁。溶酶体损伤与许多人类疾病以及正常衰老有关。然而,对溶酶体损伤的细胞应答(下文称为“溶酶体损伤应答”)的表征、功能和潜在的分子机制仍然难以捉摸。我们的新出版物揭示了溶酶体损伤可以作为迄今为止未被认识到的应激颗粒(SG)形成的启动子。SGs是信使核糖核蛋白浓缩物的集合体,通过抑制大量翻译和促进选择性蛋白质合成,帮助细胞适应溶酶体损伤的情况,维持细胞内环境的稳定。然而,关于溶酶体损伤如何启动SG形成以及SG如何连接到溶酶体损伤反应网络以组织细胞调节,仍有许多问题有待理解。SGs与几种疾病的病因学有关,SGs的操作正在成为疾病治疗的一种有前途的治疗途径。作为SG形成信号的溶酶体损伤将与多种疾病状态相关。因此,研究溶酶体损伤和SG之间的交叉是非常重要的,这与正常细胞功能以及在广泛的人类疾病中发现的功能失调的溶酶体和SG都相关。我们已经报道了一组基于半乳糖凝集素的溶酶体损伤反应,以识别、修复、回收和替换受损的溶酶体。这种基于半乳糖凝集素的检测和信号转导系统保护溶酶体质量,并启动核心细胞调节mTOR和AMPK信号传导的下游分解代谢和合成代谢过程。SG形成溶酶体损伤后的发现带来了考虑到全球翻译重编程到网络的溶酶体损伤反应。因此,我们的总体目标是确定溶酶体损伤后SG形成的信号通路及其与溶酶体损伤反应网络的连接性,以识别、修复、回收、替换和重编程受损的溶酶体。我们的长期目标是了解细胞对溶酶体损伤的反应。拟议的研究详细说明了对溶酶体损伤、SG形成的新反应的调节途径,并与我们对基于半乳糖凝集素的溶酶体损伤反应的认识相联系,可以填补溶酶体损伤领域的差距,扩展SG网络,并带来当前细胞应激知识的范式转变,开辟新的研究领域。
英文摘要
Lysosomal damage is a major threat to cellular homeostasis and survival. Lysosomal damage has been implicated in many human diseases as well as normal ageing. However, the characterizations, functions and underlying molecular mechanisms of cellular responses to lysosomal damage (referred to as “lysosomal damage responses” hereafter) remain elusive. Our new publication uncovers that lysosomal damage can act as a hitherto unappreciated initiator of stress granule (SG) formation. SGs, the aggregation of messenger ribonucleoprotein condensates, help the cell to adapt to lysosomal damage situation and maintain cellular homeostasis by suppressing bulk translation and promoting selective protein synthesis. However, much remains to be understood regarding how lysosomal damage initiates SG formation as well as how SGs connect to the network of lysosomal damage responses to organize cellular adjustment. SGs have been implicated in the etiology of several disorders, and manipulation of SGs is emerging as a promising therapeutic avenue for disease treatment. The lysosomal damage as a signal for SG formation will be of relevance for multiple disease states. Thus, it is very important to study the intersection between lysosomal damage and SGs, which is relevant both to normal cellular functions and to dysfunctional lysosomes and SGs found in a wide range of human diseases. We have reported a set of galectin-based lysosomal damage responses to recognize, repair, recycle and replace damaged lysosomes. This galectin-based detection and signal-transduction system safeguards lysosomal quality and sets off downstream catabolic and anabolic processes of core cell regulatory mTOR and AMPK signaling. The discovery of SG formation upon lysosomal damage brings the consideration of global translational reprogramming into the network of lysosomal damage responses. Therefore, our overall objective is to identify the signaling pathway of SG formation upon lysosomal damage and its’s connectivity to the network of lysosomal damage responses to recognize, repair, recycle, replace and reprogramme damaged lysosomes. Our long-term goal is to understand cellular responses to lysosomal damage. The proposed studies detail the regulatory pathway of the new response to lysosomal damage, SG formation and link with our knowledge of galectin-based lysosomal damage responses could fill the gap in lysosomal damage field, extend the network of SGs and bring a paradigm shift in the current knowledge of cell stress opening a new field of study Completion of the proposed studies will provide
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Stress granules in response to lysosomal damage
-
批准号:10808397
-
项目类别:
-
资助金额:$22.13万
-
财政年份:2023
-
负责人:Jingyue jia cassano
-
依托单位:
海外基金